ANTIBODY-RESPONSE TO HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 PROTEASE ACCORDING TO RISK GROUP AND DISEASE STAGE

被引:20
|
作者
BOUCHER, CAB
DEJAGER, MH
DEBOUCK, C
EPSTEIN, LG
DEWOLF, F
WOLFS, TFW
GOUDSMIT, J
机构
[1] MUNICIPAL HLTH SERV,DEPT INFECT DIS,AMSTERDAM,NETHERLANDS
[2] SK&F LABS,DEPT MOLEC GENET,KING OF PRUSSIA,PA 19479
[3] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,NEWARK,NJ 07103
[4] CHILDRENS HOSP,AIDS PROGRAM,NEWARK,NJ 07103
关键词
D O I
10.1128/JCM.27.7.1577-1581.1989
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:1577 / 1581
页数:5
相关论文
共 50 条
  • [1] NEUTRALIZING ANTIBODY-RESPONSE DURING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - TYPE AND GROUP SPECIFICITY AND VIRAL ESCAPE
    ARENDRUP, M
    SONNERBORG, A
    SVENNERHOLM, B
    AKERBLOM, L
    NIELSEN, C
    CLAUSEN, H
    OLOFSSON, S
    NIELSEN, JO
    HANSEN, JES
    JOURNAL OF GENERAL VIROLOGY, 1993, 74 : 855 - 863
  • [2] ABNORMALITIES OF MEASLES ANTIBODY-RESPONSE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION
    BRUNELL, PA
    VIMAL, V
    SANDHU, M
    COURVILLE, TM
    DAAR, E
    ISRAELE, V
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (05): : 540 - 548
  • [3] MATERNAL ANTIBODY-RESPONSE AT DELIVERY AND PERINATAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN AFRICAN WOMEN
    LALLEMANT, M
    BAILLOU, A
    LALLEMANTLECOEUR, S
    NZINGOULA, S
    MAMPAKA, M
    MPELE, P
    BARIN, F
    ESSEX, M
    LANCET, 1994, 343 (8904) : 1001 - 1005
  • [4] CLASS-SPECIFIC ANTIBODY-RESPONSE TO PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES IN MEN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1
    JANOFF, EN
    DOUGLAS, JM
    GABRIEL, M
    BLASER, MJ
    DAVIDSON, AJ
    COHN, DL
    JUDSON, FN
    JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (05) : 983 - 990
  • [5] DEVELOPMENT OF THE ANTI-GPL20 ANTIBODY-RESPONSE DURING SEROCONVERSION TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    MOORE, JP
    CAO, YZ
    HO, DD
    KOUP, RA
    JOURNAL OF VIROLOGY, 1994, 68 (08) : 5142 - 5155
  • [6] Regulation of intracellular human immunodeficiency virus type-1 protease activity
    Gatlin, J
    Arrigo, SJ
    Schmidt, MG
    VIROLOGY, 1998, 244 (01) : 87 - 96
  • [7] ISOTYPIC RESTRICTION OF THE ANTIBODY-RESPONSE TO HUMAN IMMUNODEFICIENCY VIRUS
    KHALIFE, J
    GUY, B
    CAPRON, M
    KIENY, MP
    AMEISEN, JC
    MONTAGNIER, L
    LECOCQ, JP
    CAPRON, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1988, 4 (01) : 3 - 9
  • [8] RELATIONSHIP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEQUENCE HETEROGENEITY TO STAGE OF DISEASE
    MCNEARNEY, T
    HORNICKOVA, Z
    MARKHAM, R
    BIRDWELL, A
    ARENS, M
    SAAH, A
    RATNER, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) : 10247 - 10251
  • [9] AUTOLOGOUS ANTIBODY-RESPONSE AGAINST THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATED FROM INFECTED HUMANS
    HOLMBACK, K
    KUSK, P
    HULGAARD, EF
    BUGGE, TH
    SCHEIBEL, E
    LINDHARDT, BO
    JOURNAL OF VIROLOGY, 1993, 67 (03) : 1612 - 1619
  • [10] INDIRECT IMMUNOFLUORESCENCE FOR THE DETECTION OF ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE-1
    MCCABE, CA
    MORRIS, EN
    LEBAR, WD
    LABORATORY MEDICINE, 1990, 21 (02) : 103 - 104